CryoLife, Inc. (CRY) Tops Q3 EPS by 4c; Guides Up
CryoLife, Inc. (NYSE: CRY) reported Q3 EPS of $0.08, $0.04 better than the analyst estimate of $0.04. Revenue for the quarter came in at $33.4 million versus the consensus estimate of $32.45 million.
CryoLife, Inc. sees FY2012 EPS of $0.25-0.27, versus prior guidance of $0.23-0.23 and the consensus of $0.25. CryoLife, Inc. sees FY2012 revenue of $131-133 million, versus prior guidance of $129-133 million and the consensus of $132 million.
CryoLife, Inc. sees FY2012 EPS of $0.25-0.27, versus prior guidance of $0.23-0.23 and the consensus of $0.25. CryoLife, Inc. sees FY2012 revenue of $131-133 million, versus prior guidance of $129-133 million and the consensus of $132 million.
For earnings history and earnings-related data on CryoLife, Inc. (CRY) click here.